All tea'd up

Food Technology

Volumn 58, Issue 7, 2004, Pages 71-72

  Ohr, Linda Milo ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLADDER CANCER; LEUKEMIA; LOW-DENSITY-LIPOPROTEIN (LDL); SMOKING DAMAGE;

ANTIOXIDANTS; CHOLESTEROL; DISEASES; DNA; ENZYMES; FOOD PRODUCTS; PATIENT MONITORING; TUMORS;

HEALTH CARE;

CAMELLIA SINENSIS;

EID: 3242710536     PISSN: 00156639     EISSN: None     Source Type: Trade Journal    
DOI: None     Document Type: Review

References (7)

1. Blumberg, J. 2003. Introduction to the proceedings of the Third international Scientific Symposium on Tea and Human Health. J. Nutr. 133: 3244S-3246S.
2. Chyu, K., Babbidge, S.M., Zhao, X., Dandillaya, R., Rietveld, A.G., Yano, J., Dimayuga, P.O., Cercek, B., and Shah, P.K. 2004, Differential effects of green tea-derived catechin on developing versus established atherosclerosis in apolipo-proteln E-null mice. Circulation 109: 2448-2453.
3. Kemberling, J.K., Hampton, J.A., Keck, R.W., Gomez, M.A., and Selman, S.H. 2003, Inhibition of bladder tumor growth by the green tea derivative epigallocatechin-3-gallate. J. Urology 170: 773-776.
4. Lee, Y.K., Bone, N.D., Strege, A.K., Jelinek, D.F., and Kay, N.E. 2004, VEGF receptor phosphorylation status and apoptosis is modulated by a green tea component, epigallo-catechin-3-gallate (EGCG) in B cell chronic lymphocyte leukemia. Blood. Prepublished online March 2.
5. Maron, D.J., Lu, G.P., Cai, N.S., Wu, Z.G., Li, Chen, Y.H., Zhu, J.Q, Jin, X.J., Wouters, B.C., and Zhao, J. 2003. Cholesterol-lowering effect of a theaflavin-enriched green tea extract. Arch. Intern. Med. 63: 1448-1453.
6. Palermo, C.M., Hernando, J.I.M., Dertinger, S.D., Kende, A.S., and Gasiewicz, T.A. 2003. Identification of potential aryl hydrocarbon receptor antagonists in green tea. Chem. Res. Toxicol. 16: 865-872.
7. Strax, J. 2004. Green and black tea polyphenols consumption results in slower prostate cancer cell growth. April 23. PSA Rising, New York, www.psa-rising.com/eatingwell.